Other languages Bairong Inc.

Equities

Delayed Hong Kong S.E. Other stock markets 03:32:38 29/04/2024 BST			5-day change	1st Jan Change
9.88 ^HKD	+3.67%		+6.47%	-27.00%

04-15	Bairong Inc. Announces the Resignation of Cathryn Xie Jianing as Executive Director	CI
03-25	Bairong's 2023 Profit Jumps as Revenue Surges 31%	MT

Bairong Inc. Announces the Resignation of Cathryn Xie Jianing as Executive Director	04-15
Bairong's 2023 Profit Jumps as Revenue Surges 31%	03-25
Bairong Inc. announces an Equity Buyback for HKD 250 million worth of its shares.	03-25
Bairong Inc. authorizes a Buyback Plan.	03-24
Bairong Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-24
Bairong Inc. Announces Management Changes	11-20
Bairong Inc. Announces Director Changes	20/10/23
Bairong Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	18/09/23
Bairong's H1 Attributable Profit More Than Doubles	23/08/23
Bairong Inc. Announces Board and Committee Changes	22/08/23
Bairong Inc. commences an Equity Buyback Plan for 50,267,339 shares, representing 10% of its issued share capital, under the authorization approved on May 16, 2023.	17/05/23
Bairong Swings to Attributable Profit in 2022 on Absence of Fair Value Losses	23/03/23
Bairong Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	22/03/23
Bairong Expects Swing to Profit in 2022; Shares Climb 9%	16/02/23
Bairong Inc. Provides Earnings Guidance for the Year Ended December 31, 2022	15/02/23
Bairong Inc. Announces Board Changes	13/01/23
Sihuan Pharmaceutical's Biopharmaceutical Unit Closes 580 Million Yuan Round of Financing; Shares Up 4%	04/01/23
ICBC Chief Business Officer Resigns	12/12/22
Bairong's January-September Revenue Climbs 25%	14/11/22
Bairong Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	13/09/22

No results for this search